Alexey V. Feoktistov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexey V. Feoktistov has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anna V. Tvorogova
Institute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia
4 shared publications - Daria Mikhailovna Yurkina
Institute of Gene Biology (RAS), Moscow 119334, Russia
4 shared publications - Denis V. Yashin
Institute of Gene Biology (RAS), Moscow 119334, Russia
4 shared publications - Elena Anatolievna Romanova
Institute of Gene Biology (RAS), Moscow 119334, Russia
4 shared publications - Lidia Pavlovna Sashchenko
Institute of Gene Biology (RAS), Moscow 119334, Russia
4 shared publications N. V. Soshnikova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
2 shared publications
Latest Publications
- Open Access
- 7 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9750
Hsp70 Peptides Induce TREM-1-Dependent and TREM-1-Independent Activation of Cytotoxic Lymphocytes
The novel data show that the Hsp70 protein is a potent activator of the immune system. Using limited trypsinolisis, we have identified the epitopes of Hsp70 responsible for TREM-1-dependent and TREM-1-independent cytotoxicity. The 11aa N9 peptide (AMTKDNNLLGR) contains nine amino acids that correspond to the amino acid sequence of the known TKD peptide. Also, like TKD, this peptide does not interact with the TREM-1 receptor but activates CD94+ NK cells that kill tumor cells by secreting granzymes and inducing apoptosis. The 16aa peptide N7 (SDNQPGVLIQVYEGEK) interacts with the TREM-1 receptor and induces the activation of NK cells and cytotoxic T lymphocytes at different time points. T-lymphocytes activated by this peptide induce two alternative processes of cell death in HLA-negative tumor cells, apoptosis and necroptosis, through the interaction of the FasL lymphocyte with the Fas receptor of the tumor cell. A shortened fragment of this peptide, N7.1 (SDNQPGVL), has been identified that inhibits the interaction of TREM-1 with its ligands. This peptide has shown protective effects in the development of sepsis in mice. The results obtained can be used in antitumor and anti-inflammation therapy.
- 7 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9750
Open AccessHsp70 Peptides Induce TREM-1-Dependent and TREM-1-Independent Activation of Cytotoxic Lymphocytes
The novel data show that the Hsp70 protein is a potent activator of the immune system. Using limited trypsinolisis, we have identified the epitopes of Hsp70 responsible for TREM-1-dependent and TREM-1-independent cytotoxicity. The 11aa N9 peptide (AMTKDNNLLGR) contains nine amino acids that correspond to the amino acid sequence of the known TKD peptide. Also, like TKD, this peptide does not interact with the TREM-1 receptor but activates CD94+ NK cells that kill tumor cells by secreting granzymes and inducing apoptosis. The 16aa peptide N7 (SDNQPGVLIQVYEGEK) interacts with the TREM-1 receptor and induces the activation of NK cells and cytotoxic T lymphocytes at different time points. T-lymphocytes activated by this peptide induce two alternative processes of cell death in HLA-negative tumor cells, apoptosis and necroptosis, through the interaction of the FasL lymphocyte with the Fas receptor of the tumor cell. A shortened fragment of this peptide, N7.1 (SDNQPGVL), has been identified that inhibits the interaction of TREM-1 with its ligands. This peptide has shown protective effects in the development of sepsis in mice. The results obtained can be used in antitumor and anti-inflammation therapy.
- Open Access
- 25 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4069
Shortened PGLYRP1 Peptides Regulate Antitumor Activity of Cytotoxic Lymphocytes via TREM-1 Receptor: From Biology to Bioinformatics
The pro-inflammatory immune response plays an important role in protecting the body from pathogens and tumors. In this study, we were able to identify three peptides of the innate immunity protein PGLYRP1 (Tag7) that could regulate the activity of the TREM-1 receptor. TREM-1 receptor activation on monocytes triggers the appearance of antitumor lymphocytes. All three peptides studied (17.0, N9, and N15) bind with the TREM-1 receptor with the Kds 1.32 ± 0.2 nM, 9.66 ± 0.5 nM, and 7.43 ± 0.4 nM, respectively. An N9 peptide inhibiting the activity of the receptor was identified in addition to two peptides (N9 and N15) that jointly trigger the activation of the receptor. The conducted molecular docking study revealed amino acid residues (Ile57, Ile58, Glu106, Ser108, Leu110, Tyr116, Pro118, Pro119, Arg130, and Val 132), necessary for various functions of peptides, providing important knowledge for understanding the mechanism of activation of this receptor that can also serve as a basis for the development of therapeutic drugs to regulate its activity in the treatment of autoimmune diseases and tumors.
- 25 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4069
Open AccessShortened PGLYRP1 Peptides Regulate Antitumor Activity of Cytotoxic Lymphocytes via TREM-1 Receptor: From Biology to Bioinformatics
The pro-inflammatory immune response plays an important role in protecting the body from pathogens and tumors. In this study, we were able to identify three peptides of the innate immunity protein PGLYRP1 (Tag7) that could regulate the activity of the TREM-1 receptor. TREM-1 receptor activation on monocytes triggers the appearance of antitumor lymphocytes. All three peptides studied (17.0, N9, and N15) bind with the TREM-1 receptor with the Kds 1.32 ± 0.2 nM, 9.66 ± 0.5 nM, and 7.43 ± 0.4 nM, respectively. An N9 peptide inhibiting the activity of the receptor was identified in addition to two peptides (N9 and N15) that jointly trigger the activation of the receptor. The conducted molecular docking study revealed amino acid residues (Ile57, Ile58, Glu106, Ser108, Leu110, Tyr116, Pro118, Pro119, Arg130, and Val 132), necessary for various functions of peptides, providing important knowledge for understanding the mechanism of activation of this receptor that can also serve as a basis for the development of therapeutic drugs to regulate its activity in the treatment of autoimmune diseases and tumors.
- Open Access
- 31 March 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (7) , 3900
The 12-Membered TNFR1 Peptide, as Well as the 16-Membered and 6-Membered TNF Peptides, Regulate TNFR1-Dependent Cytotoxic Activity of TNF
Understanding the exact mechanisms of the activation of proinflammatory immune response receptors is very important for the targeted regulation of their functioning. In this work, we were able to identify the sites of the molecules in the proinflammatory cytokine TNF (tumor necrosis factor) and its TNFR1 (tumor necrosis factor receptor 1), which are necessary for the two-stage cytotoxic signal transduction required for tumor cell killing. A 12-membered TNFR1 peptide was identified and synthesized, interacting with the ligands of this receptor protein’s TNF and Tag7 and blocking their binding to the receptor. Two TNF cytokine peptides interacting with different sites of TNFR1 receptors were identified and synthesized. It has been demonstrated that the long 16-membered TNF peptide interferes with the binding of TNFR1 ligands to this receptor, and the short 6-membered peptide interacts with the receptor site necessary for the transmission of a cytotoxic signal into the cell after the ligands’ interaction with the binding site. This study may help in the development of therapeutic approaches to regulate the activity of the cytokine TNF.
- 31 March 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (7) , 3900
Open AccessThe 12-Membered TNFR1 Peptide, as Well as the 16-Membered and 6-Membered TNF Peptides, Regulate TNFR1-Dependent Cytotoxic Activity of TNF
Understanding the exact mechanisms of the activation of proinflammatory immune response receptors is very important for the targeted regulation of their functioning. In this work, we were able to identify the sites of the molecules in the proinflammatory cytokine TNF (tumor necrosis factor) and its TNFR1 (tumor necrosis factor receptor 1), which are necessary for the two-stage cytotoxic signal transduction required for tumor cell killing. A 12-membered TNFR1 peptide was identified and synthesized, interacting with the ligands of this receptor protein’s TNF and Tag7 and blocking their binding to the receptor. Two TNF cytokine peptides interacting with different sites of TNFR1 receptors were identified and synthesized. It has been demonstrated that the long 16-membered TNF peptide interferes with the binding of TNFR1 ligands to this receptor, and the short 6-membered peptide interacts with the receptor site necessary for the transmission of a cytotoxic signal into the cell after the ligands’ interaction with the binding site. This study may help in the development of therapeutic approaches to regulate the activity of the cytokine TNF.
- Open Access
- 3 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 627
The Interaction of HMGB1 with the Proinflammatory TREM-1 Receptor Generates Cytotoxic Lymphocytes Active against HLA-Negative Tumor Cells
High mobility group protein (HMGB1) is secreted by myeloid cells and cells of damaged tissues during inflammation, causing inflammatory reactions through various receptors, including TLRS and RAGE. TREM-1 is considered to be one of the potential HMGB1 receptors. In this work, we have shown that the HMGB1 protein is able to bind to the TREM-1 receptor at high affinity both in solution and on the cell surface. This binding causes lymphocytes to release cytokines IL-2, IL-1b, IL-6, TNF and Ifny into the medium, which leads to the appearance of cytotoxic lymphocytes in PBMC capable of lysing HLA-negative tumor cells. Expanding the spectra of proinflammatory receptor ligands and understanding the mechanisms of their action is essential for the creation of new immunotherapy pathways.
- 3 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 627
Open AccessThe Interaction of HMGB1 with the Proinflammatory TREM-1 Receptor Generates Cytotoxic Lymphocytes Active against HLA-Negative Tumor Cells
High mobility group protein (HMGB1) is secreted by myeloid cells and cells of damaged tissues during inflammation, causing inflammatory reactions through various receptors, including TLRS and RAGE. TREM-1 is considered to be one of the potential HMGB1 receptors. In this work, we have shown that the HMGB1 protein is able to bind to the TREM-1 receptor at high affinity both in solution and on the cell surface. This binding causes lymphocytes to release cytokines IL-2, IL-1b, IL-6, TNF and Ifny into the medium, which leads to the appearance of cytotoxic lymphocytes in PBMC capable of lysing HLA-negative tumor cells. Expanding the spectra of proinflammatory receptor ligands and understanding the mechanisms of their action is essential for the creation of new immunotherapy pathways.
- 8 December 2023
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 513 (1) , 332-336
Chromatin Remodeling Complex PBAF Activates and Represses Inflammatory Genes
The PBAF chromatin remodeling complex regulates chromatin state and gene transcription in higher eukaryotes. In this work, we studied the role of PBAF in the regulation of NF-κB-and JAK/STAT-dependent activation of inflammatory genes. We performed knockdown of specific module subunit BAF200, which resulted in destruction of the entire PBAF specific module and changed the level of the genes transcription of both pathways. PBAF can be both an activator and a repressor of inflammatory genes. Thus, PBAF is an important regulator of inflammatory gene expression.
- 8 December 2023
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 513 (1) , 332-336
Chromatin Remodeling Complex PBAF Activates and Represses Inflammatory Genes
The PBAF chromatin remodeling complex regulates chromatin state and gene transcription in higher eukaryotes. In this work, we studied the role of PBAF in the regulation of NF-κB-and JAK/STAT-dependent activation of inflammatory genes. We performed knockdown of specific module subunit BAF200, which resulted in destruction of the entire PBAF specific module and changed the level of the genes transcription of both pathways. PBAF can be both an activator and a repressor of inflammatory genes. Thus, PBAF is an important regulator of inflammatory gene expression.
- 14 April 2022
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 56 (2) , 182-195
Role of the SWI/SNF Chromatin Remodeling Complex in Regulation of Inflammation Gene Expression
Процесс воспаления – естественный защитный ответ организма на проникновение чужеродных веществ и молекул. В активации генов воспаления участвует множество белков, сигнальных каскадов и факторов транскрипции. Их координированная работа приводит к изменению экспрессии провоспалительных генов. Состояние хроматина генов, отвечающих на воспалительные стимулы, считается основным фактором, определяющим связывание активаторов транскрипции с регуляторными элементами, и ключевым механизмом в индукции воспалительных генов. Быстрое изменение состояния хроматина, создание открытой структуры и снятие “нуклеосомного барьера” облегчает связывание транскрипционных факторов и инициацию транскрипции. Этот процесс реализуется путем привлечения на хроматин комплексов, модифицирующих и ремоделирующих хроматин. Один из важнейших комплексов, реструктурирующих структуру хроматина в процессе активации генов, – мультисубъединичный комплекс SWI/SNF. SWI/SNF регулирует экспрессию генов воспаления через взаимодействие с факторами транскрипции, в том числе с компонентами сигнального пути NF-κB. Вариабельность субъединиц этого комплекса определяет специфичность связывания с хроматином и активаторами транскрипции. В данном обзоре рассмотрена роль SWI/SNF в регуляции генов воспаления, описано его взаимодействие с хроматином и молекулярные механизмы рекрутирования комплекса SWI/SNF на промоторы.
- 14 April 2022
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 56 (2) , 182-195
Role of the SWI/SNF Chromatin Remodeling Complex in Regulation of Inflammation Gene Expression
Процесс воспаления – естественный защитный ответ организма на проникновение чужеродных веществ и молекул. В активации генов воспаления участвует множество белков, сигнальных каскадов и факторов транскрипции. Их координированная работа приводит к изменению экспрессии провоспалительных генов. Состояние хроматина генов, отвечающих на воспалительные стимулы, считается основным фактором, определяющим связывание активаторов транскрипции с регуляторными элементами, и ключевым механизмом в индукции воспалительных генов. Быстрое изменение состояния хроматина, создание открытой структуры и снятие “нуклеосомного барьера” облегчает связывание транскрипционных факторов и инициацию транскрипции. Этот процесс реализуется путем привлечения на хроматин комплексов, модифицирующих и ремоделирующих хроматин. Один из важнейших комплексов, реструктурирующих структуру хроматина в процессе активации генов, – мультисубъединичный комплекс SWI/SNF. SWI/SNF регулирует экспрессию генов воспаления через взаимодействие с факторами транскрипции, в том числе с компонентами сигнального пути NF-κB. Вариабельность субъединиц этого комплекса определяет специфичность связывания с хроматином и активаторами транскрипции. В данном обзоре рассмотрена роль SWI/SNF в регуляции генов воспаления, описано его взаимодействие с хроматином и молекулярные механизмы рекрутирования комплекса SWI/SNF на промоторы.